F-Value Reports for Child Resistant Packaging (CRP)

Our F-value reports for child-resistant packaging ensure compliance with standards, preventing child ingestion. Our expert toxicologists provide high-quality, evidence-based assessments quickly, safeguarding children’s health.

F-value Reports for Child-resistant Packaging (CRP)

Child-resistant Packaging (CRP) reduces child mortality/adverse effects from the unintentional ingestion of oral prescription drugs. CRPs are typically designed by modifying foil and blister materials, adhesives, blister pocket orientation, and wadding materials of container closure systems.

The “F” value, or Failure Value, is the count of drug units that can cause serious harm in a 25lb (11.4kg) child. For highly toxic drugs, “F” is usually set at F1, meaning a single unit is a failure. Less toxic drugs have higher “F” values, like F8. When a child gets access to a 9th unit, F8 restrictions are typically applied.

“F” value Calculation

F-values reports for CRP are calculated for a substance with multiple types of packaging (e.g. Blister, bottles, etc). Based on the derived F-value, the packaging is designed for the medicinal product.

“F” value Calculation process involves systematic collection and analysis of acute and repeated dose toxicity data along with adverse health effects observed in humans. In addition to this, clinical trial and post-marketing data in adults, pharmacokinetic (PK), and pharmacodynamics (PD) data are considered during data analysis. In the absence of substance-specific information, a read-across strategy using information from structurally or functionally similar compounds is used. Based on an overall assessment, a scientifically appropriate Point of Departure (POD) in terms of a numerical value is selected for 'F' value calculation. The "F" value typically ranges between 1 and 8.

F-value Reports for Child-resistant Packaging (CRP)

  • ‘F-value’ calculation reports in compliance with the Electronic Code of Federal Regulations (E-CFR), Title 16 - Commercial Practices Chapter II - Consumer Product Safety Commission, and Poison Prevention Packaging: A Guide for Healthcare Professionals, U.S. Consumer Product Safety Commission.
  • Regulatory knowledge and experience in the preparation of high-quality F-Value reports for simple to complex products.
  • Reports submitted to several clients across the globe.
F-value Calculation for Child-resistant Packaging
  • Fast turn-around time
  • Reports prepared by highly experienced and qualified toxicologists.
  • Reports reviewed and approved by certified toxicologists.
  • Robust quality control checks, right from document compilation to sign-off.
  • Flexibility to adapt to customer-specific templates and requirements like priority delivery of reports within the shortest time.
  • Regulatory/health authority query responses related to F value.
 F-value Calculation for Child-resistant Packaging

Get expert F-value reports for safer child-resistant packaging

Get Started

Celebrating Customers Success

 

Medicinal Products

Medical Writing

India

A big thanks to Freyr team for the support they have provided to us on priority. We really appreciate the extra effort that the Freyr team has put into providing the reports on time. We are looking forward for a continuous business association with Freyr.

Head of Quality Assurance

 

Medicinal Products

Medical Writing

India

A big thanks to the Freyr team for the support they have provided to us on priority. We really appreciate the extra effort that the Freyr team has put into providing the reports on time. We are looking forward to a continuous business association with Freyr.​

Head of Quality Assurance​

India-based, Leading Pharma Contract Manufacturing Organization​

 

Medicinal Products

Medical Writing

UK

We are extremely happy to inform you that the BLA was successfully submitted to the FDA. We convey our sincere gratitude to the Freyr team, who worked diligently, tirelessly, and very closely with our Bridgewater and Beijing teams over the past several months to accomplish this monumental feat on time. Freyr’s team went beyond the call of duty to make this BLA submission come true. We truly appreciate Freyr’s flexibility and eagerness to work with us to accomplish aggressive goals. Look forward to your perennial support and our continued relationship and beyond. ​

Global CMC Technical Lead​

China-based, Leading Innovator Pharmaceutical Company​

 

Medicinal Products

Medical Writing

USA

Thank you, Freyr team. I appreciate your professionalism, dedication, and hard work. You’ve gone above and beyond to ensure all deliverables were met ahead of schedule throughout the project and have done a great job managing a challenging group of products. I appreciate your attention to detail and follow-up on the large workload you’ve managed. It’s been a pleasure working with you, and I wish you and your family all the best in the future!​

Director, Global Labeling Management – Labeling Cluster Head Global Product ​ Development, Global Regulatory Affairs

US-based, Multinational Pharmaceutical and Biotechnology Company​

 

Medicinal Products

Medical Writing

Vietnam​

Thank you so much for being a great partner in our Regulatory compliance journey.

As Asian countries move towards having safety assessments as a key requirement, your support has helped us significantly in fulfilling those requirements well ahead of our competitors in Vietnam. ​

In fact, I shared your contact with our regulatory officers so that they can share it across the industry if the safety assessments become necessary.

Lead, R&D/Personal Care

India-based, Multinational Consumer Goods Company​

 

Medicinal Products

Medical Writing

USA

Kudos to you all for the brilliant teamwork !! Alone, we can do so little; together, we can do so much.

Look forward to the next milestone and collaboration on new projects in the future.

SVP - R&D ( Finished Dosage Form)​

US-based, CRO Company that Focuses on Material Science and Engineering for Drug Development​